Royalty Interest on Cystic Fibrosis Foundation Therapeutics Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Royalty Interest on Cystic Fibrosis Foundation Therapeutics General Information

Description

A royalty right of pharmaceutical drugs. The portfolio consists of a treatment package for a genetic disease named cystic fibrosis.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Buildings and Property
Other Industries
Other Healthcare
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • -
  • Bethesda, MD
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Royalty Interest on Cystic Fibrosis Foundation Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Royalty Interest on Cystic Fibrosis Foundation Therapeutics‘s full profile, request access.

Request a free trial

Royalty Interest on Cystic Fibrosis Foundation Therapeutics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Royalty Interest on Cystic Fibrosis Foundation Therapeutics‘s full profile, request access.

Request a free trial